Fundz

Akelos, Inc. reported raising $295,000 in an initial SEC Form D filing, from an offering of $295,000

PRIVATENov 28, 2018

Amount Raised

$295,000

$295,000 sold, per SEC Form D (first sale Nov 28, 2018)

Round Type

Seed

New YorkBiotechnology

Quick answer

Akelos raised $295,000 in a Seed round, dated November 28, 2018. Akelos is based in New York, New York, United States.

How much did Akelos raise?
Akelos raised $295,000 in a Seed round on November 28, 2018.
What does Akelos do?
Akelos Inc. is a biopharmaceutical clinical company focused on the translation of innovative science into treatment.
Where is Akelos based and how big is it?
Akelos is based in New York, New York, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Akelos that raised within 45 days of this round, from Fundz verified event records.

  • BELLUS Health Inc. raised $1.3M (Seed) on January 11, 2019.
  • NERx Biosciences, Inc. raised $850K (Seed) on January 11, 2019.
  • Embleema raised $3M (Seed) on January 9, 2019.
  • Sirnaomics, Inc. raised $25M on January 8, 2019.
  • USBC raised $29K on January 8, 2019.
  • Medical 21 raised an undisclosed amount on January 8, 2019.

Who to call at Akelos, and when

A new round usually means Akelos is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Akelos raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Akelos, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Akelos. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Akelos

Location

215 EAST 68TH STREET, SUITE 26B

New York, New York, United States

About

Akelos Inc. is a biopharmaceutical clinical company focused on the translation of innovative science into treatment. The company currently is developing novel non-narcotic drugs for the treatment of neuropathic pain. The goal of Akelos is to address some of today’s most pressing areas of unmet needs.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Akelos raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Akelos's next move

See what Strategic adds

Akelos raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.